Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Research Letter entitled “Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- and High-Risk Prostate Cancer Across the United States” published online June 30, 2016, and to be published in the September print issue of JAMA Oncology,1 an error occurred in the Figure key. In that key, the lighter graph bars were indicated as representing intermediate risk of prostate cancer and the darker bars as high risk. These should be replaced in the key with darker shading to represent intermediate risk of prostate cancer and lighter shading to represent high risk. This article was corrected online and will be correct in the print issue.
Incorrect Figure Key. JAMA Oncol. 2016;2(8):1099. doi:10.1001/jamaoncol.2016.3365
Artificial Intelligence Resource Center